| Term 
 
        | MOA:   Block sodium and chloride retention in Loop of Henle   Decrease preload and CVP   Rapid onset, lasts 2 hours   Kidney fxn diminished--loop diuretics may still be effective |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA:   Pull fluid into renal tubule, reducing cerebral edema and increasing urine production |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   Edema r/t HF, liver failure, renal disease, HTN |  | Definition 
 
        | INDICATIONS:   Loop Diuretics |  | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   Head trauma, early oliguric phase of renal failure   Decrease cerebral edema and ICP |  | Definition 
 
        | INDICATIONS:   Osmotic Diuretic |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | IMPLICATIONS: -Sulfonamide allergy -Electrolyte imbalance -Hepatic Coma   Interaxns: corticosteroids and digoxin--> hypokalemia Increased serum uric acid, glucose, AST, ALT   TOXICITY: fluid & electrolyte replacement |  | Definition 
 
        | IMPLICATIONS:   Loop Diuretics |  | 
        |  | 
        
        | Term 
 
        | MOA:   Vaughn Williams Classification Class I Class II beta blockers Class III prolongs repolarization Class IV calcium channel blocker |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   V Tach V Dys A Fib A Flutter |  | Definition 
 
        | INDICATIONS:   Antidysrhythmics |  | 
        |  | 
        
        | Term 
 
        | SE:   Antidysrhythmic hypersensitivity, n/v/d, headaches, blurred vision   Overdose: Mgmt consists of circulatory and ventilatory support; Symptomatic Treatment |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | IMPLICATIONS:   Contra: 2nd/3rd degree Heart Block, cardiogenic shock Interaxns: Increases anticoagulant and Dilantin effects; can cause dyrhythmmmia when combined with other antidysrhythmics   Drink plenty of fluids unless contraindicated   Cardiac monitoring |  | Definition 
 
        | IMPLICATIONS:   Antidysrhythmics |  | 
        |  | 
        
        | Term 
 
        | MOA:   Relax vascular smooth muscle Decrease preload=decreased O2 consumption Dilation of coronary arteries and collaterals |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   Angina treatment + Prophylaxis CHF Acute MI Raynaud's |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SE:   Headaches (Most common) BradyC Postural hypotension dizziness weakness confusion Nightmares |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | IMPLICATIONS:   Contra: Pediatrics, Geriatrics (lower doses, risk of hypotension), pregnancy, cerebral hemorrhage, impaired hepatic fxn Caution: Viagra   Don't touch pastes/put directly over heart Always carry SL for emergencies Medication vacation; Avoid changing brands |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA:   decrease myocardial contraxn decrease automaticity of SA node decrease conduction through AV node decrease force of smooth muscle contraxn |  | Definition 
 
        | MOA:   Calcium Channel Blocker |  | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   angina (2nd line of choice; beta blockers 1st) HTN (best for African Americans & geriatrics) arrhythmias |  | Definition 
 
        | INDICATIONS:   Calcium Channel Blockers |  | 
        |  | 
        
        | Term 
 
        | SE:   Overdose: monitor cardiac and respiratory fxn; lavage emetics; 2nd and 3rd degree heartblocks   hypotension bradyC, asystole |  | Definition 
 
        | SE:   Calcium Channel Blockers |  | 
        |  | 
        
        | Term 
 
        | IMPLICATIONS:   Contra: Hypersensitivity, Sick Sinus Syndrome, Heart Blocks, Lactation |  | Definition 
 
        | IMPLICATIONS:   Calcium Channel Blocker |  | 
        |  | 
        
        | Term 
 
        | MOA:   Adrenergic: Block SNS stimulation (beta 1 cardioselective, beta 2 nonselective)   Compete with natural epi and norepi, blocking SNS stimulation of receptor sites   Decrease HR, conduction, and contractility |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   Angina (1st choice) Inhibit catecholamines Post MI dysrhythmias HTN (Caucasians) Migraine Head Ache |  | Definition 
 
        | INDICATIONS:   Adrenergic Blockers |  | 
        |  | 
        
        | Term 
 
        | SE:   Extended actions acute withrdawal w/c exacerbates angina and precipitates MI MASK SIGNS OF HYPOGLYCEMIA |  | Definition 
 
        | SE:   Adrenergic Blockers Beta Blockers |  | 
        |  | 
        
        | Term 
 
        | IMPLICATIONS:   Contra: uncompensated HF, cardiogenic shock, Heart block, bradyC, pregnancy, severe pulmonary disease, Raynaud's   Taper Medication, monitor pulse Diabetic pts (signs and symptoms of hypoglycemia) Avoid OTC sympathomimetics Causes impotence in male pts |  | Definition 
 
        | IMPLICATION:   Adrenergic Blockers Beta blockers |  | 
        |  | 
        
        | Term 
 
        | MOA:   Suppress RAAS Reduce SVR, lowering BP no change in HR Increases renal perfusion |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   HTN + thiazide diuretic CHF MI Diabetic neuropathy L Ventricular Dysfunction |  | Definition 
 
        | INDICATIONS:   ACE Inhibitors |  | 
        |  | 
        
        | Term 
 
        | SE:   hypotension palpitations angina orhtostatic hypotension   chronic cough (predominant SE) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | IMPLICATIONS:   Contra: Hx angioedema, 2nd and 3rd trimester of pregnancy, renal insufficiency, geriatrics   Identify name, type, and dose of drug for pt DO NOT double dose Identify common SE Take with or without food |  | Definition 
 
        | IMPLICATIONS:   ACE inhibitors |  | 
        |  | 
        
        | Term 
 
        | MOA:   increase muscle contractility decrease conduction inotropic, chronotropics, dromotropic effects |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   HF Supraventricular Dysrhythmias Promote Diuresis |  | Definition 
 
        | INDICATIONS:   Cardiac Glycosides |  | 
        |  | 
        
        | Term 
 
        | IMPLICATIONS:   Contra: 2nd/3rd degree heart block, V Tach, V Fib   DO NOT DOUBLE DOSE DO NOT switch b/w trades and generics DO NOT increase salt intake KEEP OUT OF REACH of pets and children wear ID bracelet |  | Definition 
 
        | IMPLICATIONS:   Cardiac Glycosides |  | 
        |  | 
        
        | Term 
 
        | MOA:   Deplete norepi storage in neurotransmitter storage vesicles so that SNS is NOT stimulated   Result: decreased BP |  | Definition 
 
        | MOA:   Adrenergic Agents Central and Peripheral Acting Neuron Blocker |  | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   HTN treatment (seldom used because of frequent SE) |  | Definition 
 
        | INDICATIONS:   Adrenergic Agent Central and Peripheral Acting Neuron Blocker |  | 
        |  | 
        
        | Term 
 
        | SE:   Dry mouth, drowsiness, sedation, constipation   Headaches, sleep disturbances, nausea, rash, palpitations   Orthostatic hypotension |  | Definition 
 
        | SE:   Adrenergic Agent Central and Peripheral Acting Neuron Blocker |  | 
        |  | 
        
        | Term 
 
        | MOA:   Stimulate alpha-2 receptors in brain, decreasing sympathetic outflow from CNS in the brain (decrease epi and norepi)   Result: decreased BP because of increased stimulus to alpha-2 receptors inhibits the further release of NE END RESULT: VASODILATION |  | Definition 
 
        | MOA:   Adrenergic Agent Central Alpha-2 Agonists |  | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   Tx of HTN, usually after other agents have failed due to side effects   Tx Dysmenorrhea, menopausal flushing, glaucoma   Clonidine: mgmt of w/drawal symptoms in opioid or nicotine dependent persons |  | Definition 
 
        | INDICATIONS:   Adrenergic Agents Central Alpha-2 Agonists |  | 
        |  | 
        
        | Term 
 
        | IMPLICATIONS:   HTN drug of choice for PREGNANCY |  | Definition 
 
        | IMPLICATIONS:   Adrenergic Agents Central Alpha-2 Agonists |  | 
        |  | 
        
        | Term 
 
        | MOA: Block alpha-1 so SNS is not stimulated   RESULT: decreased BP |  | Definition 
 
        | MOA:   Adrenergic Agent Peripheral Alpha-1 antagonist |  | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   Tx HTN Relief of Sx, of BPH Mgmt of severe HF + caridiac glycosides and diuretics |  | Definition 
 
        | INDICATIONS:   Adrenergic Agents Peripheral Alpha-1 Antagonists |  | 
        |  | 
        
        | Term 
 
        | MOA:   Act in periphery of heart and blood vessels Decrease HR (beta-1 blockade) Cause vasodilation (Alpha-1 blockade) |  | Definition 
 
        | MOA:   Adrenergic Agent Dual Alpha 1 and Beta Blocker |  | 
        |  | 
        
        | Term 
 
        | MOA:   Act in periphery of heart to decrease HR |  | Definition 
 
        | MOA:   Adrenergic Agent Beta Blocker |  | 
        |  | 
        
        | Term 
 
        | MOA:   Block ACE, thus preventing formation of angiotensin II Prevent breakdown of bradykinin   Result: Decreased systemic vascular resistance (afterload); vasodilation, DECREASED BP |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   HTN HF Slow down L. Vent Hypertrophy post MI Renal protection in diabetic pts |  | Definition 
 
        | INDICATIONS:   ACE Inhibitors |  | 
        |  | 
        
        | Term 
 
        | SE:   Fatigue, headache, impaired taste, dizziness, mood changes, hyperkalemia   Dry, nonproductive cough which reverses when therapy is discontinued |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | IMPLICATIONS:   First-dose hypotension may occur   Pt K+>5.0 mEq NOT suitable for use, can potentiate LITHIUM TOXICITY |  | Definition 
 
        | IMPLICATIONS:   ACE Inhibitors |  | 
        |  | 
        
        | Term 
 
        | MOA:   Allow angiotensin I to convert to angiotensin II, but BLOCKS receptors that rcv angiotensin II   Blocks vasoconstriction and release of aldosterone |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   HTN, Adjunct in HF   May be used alone or with other agent as diuretics Primarily used in pts who cannot tolerate ACE inhibitos |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SE:   URI Headaches Dizziness, Insomnia, Diarrhea, Dyspnea, heartburn, nasal congestion, back pain, fatigue Hyperkalemia less likely to occur |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | IMPLICATIONS:   Well tolerated because does not cause cough like ACE inhibitors |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA:   Causes sm muscle relaxation by blocking calcium binding   Decreased peripheral smooth muscle tone and decreased systemic vascular resistance   RESULT: Decreased BP |  | Definition 
 
        | MOA:   Calcium Channel Blocker |  | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   Angina HTN Dyrhythmias Migraine Headaches Raynaud's |  | Definition 
 
        | INDICATIONS:   Calcium Channel Blockers |  | 
        |  | 
        
        | Term 
 
        | SE:   hypotension, palpitations, tachC, constipation, nausea, rash flushing, peripheral edema, dermatitis |  | Definition 
 
        | SE:   Calcium Channel Blockers |  | 
        |  | 
        
        | Term 
 
        | MOA:   Directly relaxes arteriolar smooth muscle   Result: decreased systemic vascular response, decreased afterload, peripheral vasodilation |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | INDICATIONS:   HTN   Emergency HTN: Sodium nitroprusside Diazoxide |  | Definition 
 
        | INDICATIONS:   Vasodilators |  | 
        |  | 
        
        | Term 
 
        | SE:   Hydralazine: Dizziness, Headaches, tachC, n/v, diarrhea, anemia, dyspnea, edema, nasal congestion   Sodium Nitroprusside: bradyC, hypotension, CYANIDE TOXICITY |  | Definition 
 | 
        |  |